Collagen Solutions PLC Collagen Solutions Supply Agreement with BBI
December 07 2015 - 1:00AM
RNS Non-Regulatory
TIDMCOS
Collagen Solutions PLC
07 December 2015
Collagen Solutions Plc
(the "Company" or the "Group")
Supply agreement with BBI Solutions
Collagen Solutions plc (AIM: COS), the developer and
manufacturer of medical grade collagen components for use in
regenerative medicine, medical devices and in-vitro diagnostics,
announces the execution of a supply agreement between Collagen
Solutions (UK) Ltd and BBI Solutions OEM Limited ("BBI").
The supply agreement which will be for an initial three year
period and on a rolling annual basis thereafter, will encompass the
supply of Collagen Solutions' medical grade materials to support
the research, pre-clinical and clinical development programmes of
BBI's broad customer base.
Commenting on the agreement, Dr Stewart White, CEO of Collagen
Solutions, said: "BBI has a renowned reputation for their knowledge
in the reagent supply, diagnostics and development space and are
therefore an excellent partner to enable collagen users to access
our high quality medical grade GMP approved materials. We are very
pleased to be working with Lyn and the team in Cardiff."
Lyn Rees, CEO of BBI Solutions added: "Our mission is to deliver
exceptional products and technologies through innovation,
partnership, effective delivery and collaboration. By working
alongside the team at Collagen Solutions we can build on our
expertise and reputation for supplying critical biological products
into regulated markets. Our developing customer base in the
advanced cellular and regenerative medicine markets are
increasingly looking for collagen compounds. As a result, it was
important for us to find a partner who can supply the high grade
collagen they require consistently. Through this relationship with
Collagen Solutions, we can continue to build our brand, improve the
quality of people's lives and further our goals for the future in
this transformational area of healthcare."
Enquiries:
Collagen Solutions Plc
David Evans, Chairman Tel: 07740 084 452
Stewart White, CEO Tel: 0141 648 9100
Panmure Gordon & Co (Nominated Tel: 0207 8862 714
Advisor and Broker) Tel: 0207 886 2905
Robert Naylor (Corporate
Finance)
Maisie Atkinson (Corporate
Broking)
Walbrook PR Ltd Tel: 020 7933 8780 or
collagen@walbrookpr.com
Anna Dunphy Mob: 07876 741 001
Mike Wort Mob: 07900 608 002
BBI Solutions
Lyn Rees, CEO Tel: 029 207 47232
About BBI Solutions OEM Limited.
BBI Solutions is a leading supplier of biological raw materials
and finished test platforms to the in-vitro diagnostic market. With
over 50 years' experience, we have grown from a small specialist
company to a global business with manufacturing sites spanning
three continents.
We deliver exceptional products and services that people
ultimately rely on to enjoy a better quality of life.
Our range of raw materials includes antigens, antibodies,
enzymes and serum and plasma products. We manufacture world
renowned labels for lateral flow and ELISA, including our gold
nanoparticles, horseradish peroxidase and alkaline phosphatase. Our
glucose oxidase is used in over 5 billion blood glucose monitoring
test strips every year.
We offer end to end outsourced development and manufacturing
services across a number of lateral flow and related platforms.
Over 25 years, we have successfully completed more than 250
projects. Using the latest technologies and platforms, customers
have come to rely on BBI to deliver next generation assay
performance.
BBI Solutions is part of the BBI Group.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRATIBLTMBJMBFA
(END) Dow Jones Newswires
December 07, 2015 02:00 ET (07:00 GMT)
Healthcare Inv (LSE:HIO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Healthcare Inv (LSE:HIO)
Historical Stock Chart
From Apr 2023 to Apr 2024